Drug profile

The FDA adverse-event record for Suanovil 50

47 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Suanovil 50. Species, reactions, and outcomes follow.

#1163 of 2,679
by report volume (all drugs)
47
adverse-event reports
12.8%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Suanovil 50 ranks #1156 of 2679 by total reports (47). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1156
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Suanovil 50 has 47 reports now versus 47 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Suanovil 50 changes

Signature read: death-coded report count at 6 is the most distinctive stamp on Suanovil 50's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
6
Deaths Reported
12.8%
Death-coded share of reports

Active Ingredients

Suanovil 50

Administration Routes

UnknownOralSubcutaneous

Species Affected

Dog 40
Cattle 6
Cat 1

Most Affected Breeds

Retriever - Labrador 9
Pit Bull 7
Retriever - Golden 4
Chihuahua 3
Holstein-Friesian also known as Holstein 3
Crossbred Canine/dog 3
Cattle (other) 3
Terrier - Cairn 2
Shepherd Dog (unspecified) 2
Bulldog 2

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 10
Haematuria 6
Anorexia 6
Death 6
Restlessness 5
Glazed eye 4
Adipsia 4
Hyperkalaemia 4
Hyperglycaemia 4
Haemoglobinuria 4
Hypocalcaemia 4
Weight loss 4

Outcome Breakdown

Outcome Unknown
23 (43.4%)
Recovered/Normal
12 (22.6%)
Ongoing
7 (13.2%)
Died
6 (11.3%)
Recovered with Sequela
5 (9.4%)

Suanovil 50 Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Suanovil 50 (#1163 of 2,679 by report volume); death-coded 12.8%. PlainBreed drug row · death-coded report count stamp 6 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →